According to a new report by Polaris Market Research, the global cell therapy technologies market was valued at USD 5.80 billion in 2024 and is projected to reach USD 44.43 billion by 2034, expanding at a CAGR of 22.6% from 2025 to 2034. The market is estimated at USD 7.09 billion in 2025. Growth is underpinned by rising government funding for regenerative medicine, accelerating gene-editing technology adoption, and increasing approvals of cell-based therapies across oncology and chronic-disease indications.

What Is Driving Cell Therapy Technologies Market Growth?

Demand is climbing as increased government funding for regenerative medicine research converges with rapid advancements in gene-editing precision. Biopharmaceutical companies and research institutions are prioritizing scalable cell processing technologies, pushing cell therapy technologies adoption across oncology, autoimmune, and degenerative disease treatment. Polaris analysts note that the rising global prevalence of chronic diseases, coupled with an aging population, positions the segment for sustained double-digit growth through 2034, with North America emerging as the largest revenue contributor and Asia Pacific posting the fastest incremental gains.

Key Trends Shaping the Cell Therapy Technologies Industry

Advancements in Genome Editing Technology

Tools such as CRISPR-Cas9 are enhancing the precision and efficiency of genetic modifications, enabling more effective and personalized cell therapies and reducing the risk of immune rejection, a key technology advancement fueling market expansion.

Growing Government and Institutional Funding

Increased public and private investment in regenerative medicine research is accelerating the translation of cell therapy discoveries into clinical applications, strengthening the regulatory landscape and R&D pipelines across major markets.

Expansion of Allogeneic, Off-the-Shelf Therapies

Rising interest in donor-derived allogeneic therapies is reshaping the competitive landscape, as manufacturers pursue large-scale production models that improve immediate availability and support broader patient access.

Market Segmentation: Breaking Down the Cell Therapy Technologies Market

Polaris segments the cell therapy technologies market by therapy type, technology, application, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Therapy Type

The autologous therapies segment led the market in 2024, driven by the personalized nature of treatments that use a patient's own cells to minimize the risk of immune rejection, including chimeric antigen receptor (CAR) T-cell therapies. The allogeneic therapies segment is expected to post significant growth as donor-sourced, off-the-shelf treatments gain traction for their immediate availability and large-scale manufacturing potential.

By Technology

The viral vector technology segment held the largest revenue share in 2024, given its critical role in delivering genetic material into cells for gene therapies and cell-based treatments. The genome editing technology segment is registering the highest growth rate, propelled by advancements in CRISPR-Cas9 tools and rising demand for precision genetic modification solutions.

By Application

The oncology segment accounted for the largest share in 2024, reflecting the widespread adoption of CAR T-cell treatments that have shown favorable outcomes across various cancers. The musculoskeletal segment is experiencing the highest growth rate as researchers expand regenerative approaches using engineered and native skeletal progenitor cells.

Regional Outlook: Where Is the Cell Therapy Technologies Market Growing Fastest?

North America held the largest share of the market in 2024, supported by advanced healthcare infrastructure, substantial R&D investment, and a supportive regulatory environment, with collaborations between research institutions and major pharmaceutical companies accelerating development in the region. Asia Pacific is registering the highest growth rate, driven by growing awareness of alternative therapies, rising investments, and supportive government policies, with China building local manufacturing capabilities and research infrastructure to advance regional cell therapy production.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 :

https://www.polarismarketresearch.com/industry-analysis/cell-therapy-technologies-market 

Competitive Landscape: Leading Cell Therapy Technologies Companies

Key players profiled in the report include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Lonza Group AG, Sartorius AG, Agilent Technologies Inc., Avantor, Inc., Bio-Techne Corporation, Fresenius SE & Co. KGaA, Becton, Dickinson and Company (BD), Corning Incorporated, and Terumo Corporation, who are focusing on continuous innovation and strategic collaborations to strengthen market position across the autologous-therapy and oncology segments outlined above.

Recent moves include AstraZeneca's March 2025 agreement to acquire EsoBiotec, a Belgian biotechnology company specializing in in-vivo CAR-T cell therapies, for up to USD 1 billion, and Novartis's November 2023 strategic licensing agreement with Legend Biotech to develop and manufacture CAR-T therapies targeting DLL3 for large cell neuroendocrine carcinoma.

Why It Matters for Buyers Evaluating Cell Therapy Technologies

For stakeholders researching the Cell Therapy Technologies Market, this report benchmarks market share, segment-level pricing, and forecast data — by therapy type, technology, application, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking genome editing technology as a growth adjacency.

More Trending Latest Reports By Polaris Market Research:

Gabapentin Market

Blank Apparel Market

Synchronous Condenser Market

Asia Pacific SGLT2 Inhibitors Market

Shea Butter Market

Shea Butter Market

Chicken Coop Market

Intelligent Transportation System Market

Smart Trash Bin Market